Along with the incredible potential biologics offer, there is also great pressure to discover and deliver novel treatments quickly and cost-effectively.
The perceptions some have of a career in clinical research leading to an overworked, underappreciated, paper-pushing dead end are being reversed.
In clinical research, as in so many other areas of life these days, one must have the wisdom to know the difference between a challenging scenario that calls for a digital solution versus a more practical approach.
It is crucial to improve diversity, equity, and inclusion (DEI) in clinical trials for the health and well-being of everyone.
While oncology has been slower to adopt decentralized clinical trials than other medical specialties, many oncologists realize this type of service could be a game-changer for cancer research and treatments.